Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583557 · ClinicalTrials.gov registry record · Phase 2
A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01
A Phase 2 study, sponsored by Human Genome Sciences.
- Terminated
- Registry status
- Phase 2
- Development phase
- 155
- Enrollment target
NCT00583557: Clinical Trial Phase 2 study, sponsored by Human Genome Sciences.
NCT00583557 is a Phase 2 study that was terminated before completion, run by Human Genome Sciences. The registered enrollment target is 155 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (17% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00583557, a Phase 2 study, was terminated before completion, sponsored by Human Genome Sciences.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 155 participants
- Enrollment target
Study Summary
This is a continuation trial of LymphoStat-B™ to evaluate the long-term safety in subjects with Rheumatoid Arthritis that completed study LBRA01 and benefitted from treatment.
Primary Outcome
SEE ALSO ADVERSE EVENT (AE) RESULTS SECTION.
Interventions
- DRUG belimumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
Why NCT00583557 stopped before completion
NCT00583557 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (17% higher).
The record links to 0 conditions, and to 1 intervention - of which belimumab is the first listed.
NCT00583557 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00583557 about?
NCT00583557 is a clinical study titled "A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01". This is a continuation trial of LymphoStat-B™ to evaluate the long-term safety in subjects with Rheumatoid Arthritis that completed study LBRA01 and benefitted from treatment.
What is the current status of trial NCT00583557?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 155 participants. The study started on 2005-01. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00583557?
The interventions under investigation include: belimumab (DRUG).
Who is sponsoring clinical trial NCT00583557?
This trial is sponsored by Human Genome Sciences, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00583557's enrollment target sits among peer trials
155 448th of 2000 higher than 1,553 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia